Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Radioiodine on the Nasolacrimal System.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2022
Same author

Thyroid Abnormalities in Heart Failure.

Cardiology clinics·2022
Same author

Hypothyroid Symptoms in Levothyroxine-Treated Patients.

Innovations in pharmacy·2021
Same author

Thyroid Abnormalities in Heart Failure.

Heart failure clinics·2019
Same author

Assessment of the Adequacy of Thyroid Hormone Replacement Therapy in Hypothyroidism.

Frontiers in endocrinology·2019
Same author

Thyroid Hormones and Cardiovascular Function and Diseases.

Journal of the American College of Cardiology·2018
Same journal

Intensive Care Unit and Hospital Mortality for non-COVID Critically ill Patients Before, and During the COVID-19 Pandemic in Alberta Hospitals: Retrospective, Observational Cohort Study.

Journal of intensive care medicine·2026
Same journal

Long-Acting Insulin and Hypoglycemia in Critically Ill Patients with Diabetes: A Sensitivity Analysis.

Journal of intensive care medicine·2026
Same journal

On the Distribution of Baseline Severity Markers: A Contribution to the Interpretation of Long-Acting Insulin use in Surgical ICU Patients with Type 2 Diabetes.

Journal of intensive care medicine·2026
Same journal

Remimazolam Versus Midazolam for Sedation in Mechanically Ventilated Patients with Severe Pneumonia: A Randomized Controlled Trial.

Journal of intensive care medicine·2026
Same journal

Chronic Opioid use in Adult Survivors of Pediatric ICU Admissions in Nova Scotia: A Retrospective Cohort Study.

Journal of intensive care medicine·2026
Same journal

The Middle Ground: Midline Catheter use and Trainee Involvement in US Critical Care Fellowships.

Journal of intensive care medicine·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

Amiodarone-induced thyroid dysfunction.

Sara Danzi1, Irwin Klein2

  • 1Department of Biological Sciences and Geology, Queensborough Community College, Bayside, NY, USA saradanzi@gmail.com.

Journal of Intensive Care Medicine
|September 27, 2013
PubMed
Summary
This summary is machine-generated.

Amiodarone effectively treats cardiac arrhythmias but can cause thyroid dysfunction, including thyrotoxicosis (AIT) and hypothyroidism (AIH). Monitoring thyroid function is crucial for patients on amiodarone therapy.

Keywords:
T3amiodarone-induced thyrotoxicosishearthyperthyroidismhypothyroidismthyroid hormonethyrotoxicosistriiodothyronine

Related Experiment Videos

Last Updated: May 7, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

Area of Science:

  • Endocrinology
  • Cardiology
  • Pharmacology

Background:

  • Amiodarone is a widely used antiarrhythmic drug with potential thyroid-related side effects.
  • Its structural similarity to thyroid hormones and iodine content are implicated in thyroid dysfunction.
  • Amiodarone-induced thyroid dysfunction (AITD) encompasses thyrotoxicosis (AIT) and hypothyroidism (AIH).

Observation:

  • AIT is more common in iodine-deficient regions, while AIH is prevalent in iodine-sufficient areas.
  • AIT Type 1 often occurs in patients with pre-existing thyroid conditions, whereas Type 2 results from drug-induced thyroiditis in normal glands.
  • Mixed types of AIT are also observed, complicating diagnosis and treatment.

Findings:

  • Thyroid dysfunction in amiodarone-treated patients may present as a recurrence of cardiac symptoms.
  • Comprehensive thyroid function tests, including TSH, T4, T3, and antithyroid antibodies, are essential for monitoring.
  • Treatment strategies vary based on AIT type, involving thionamides, glucocorticoids, or thyroid hormone replacement for AIH.

Implications:

  • Early detection and appropriate management of amiodarone-induced thyroid dysfunction are critical for patient outcomes.
  • Understanding the distinct mechanisms of AIT types guides therapeutic decisions.
  • Given amiodarone's long half-life, treatment effects may be delayed after drug discontinuation.